Methorapfs 20 Injection 0.4 ml
₹134.1*
MRP ₹149
10% off
₹127*
MRP ₹149
15% CB
₹22 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Methorapfs 20 Injection 0.4 ml belongs to the class of medicines called 'anti-metabolites and immunosuppressants' used to treat active rheumatoid arthritis, including polyarticular juvenile rheumatoid arthritis and severe psoriasis. Methorapfs 20 Injection 0.4 ml is also used to treat cancer such as breast cancer, cervical cancer, bladder cancer, ovarian cancer, testicular cancer, lung cancer, head and neck cancer, mycosis fungoides (type of blood cancer), bone cancer, and advanced stage non-Hodgkin's lymphomas (cancer that starts in the lymphatic system).
Methorapfs 20 Injection 0.4 ml contains 'Methotrexate' that works by interrupting the processes of the immune system that cause inflammation in the joint tissues. It reduces pain and inflammation and delays joint damage and disease progression over time. Besides this, Methorapfs 20 Injection 0.4 ml prevents and stops the growth of cancer cells, thereby helps treat cancer. Methorapfs 20 Injection 0.4 ml treats psoriasis by suppressing the overactive immune system that is responsible for causing psoriasis.
Methorapfs 20 Injection 0.4 ml will be administered by a qualified healthcare professional; do not self-administer. In some cases, Methorapfs 20 Injection 0.4 ml may cause side-effects such as nausea, vomiting, diarrhoea, unusual fatigue, dizziness, headache, loss of appetite, lowered resistance to infections, tingling sensation, leukopenia (decreased number of white blood cells), and soreness of mouth and lips. You are advised to talk to your doctor if you experience any of the side effects persistently.
Do not take Methorapfs 20 Injection 0.4 ml if you are pregnant or breastfeeding. Methorapfs 20 Injection 0.4 ml may cause dizziness and fatigue, so avoid driving or operating machinery. Avoid consuming alcohol whilst on treatment with Methorapfs 20 Injection 0.4 ml. If you are due to undergo any surgery, including dental surgery, inform the doctor that you are receiving Methorapfs 20 Injection 0.4 ml. Do not have any vaccinations during treatment with Methorapfs 20 Injection 0.4 ml without consulting your doctor. Inform your doctor about your medications and health condition to rule out any unpleasant side effects.
Methorapfs 20 Injection 0.4 ml belongs to the class of medicines called 'anti-metabolites and immunosuppressants' used to treat active rheumatoid arthritis including polyarticular juvenile rheumatoid arthritis (arthritis in children) and severe psoriasis. Methorapfs 20 Injection 0.4 ml helps treat rheumatoid arthritis by interrupting the processes of the immune system that cause inflammation in the joint tissues. It reduces pain and inflammation and delays joint damage and disease progression over time. Methorapfs 20 Injection 0.4 ml treats psoriasis by suppressing the overactive immune system that is responsible for causing psoriasis. Methorapfs 20 Injection 0.4 ml is used to treat breast cancer, lung cancer, head and neck cancer, mycosis fungoides (type of blood cancer), and advanced stage non-Hodgkin's lymphomas (cancer that starts in the lymphatic system). Methorapfs 20 Injection 0.4 ml prevents and stops the growth of cancer cells by interfering with DNA production.
Do not take Methorapfs 20 Injection 0.4 ml if you are allergic to any of its contents; if you are pregnant or breastfeeding. Inform your doctor if you have immunodeficiency conditions, bone marrow problems, low white blood cell count, low platelet count, serious anaemia, liver problems due to alcohol abuse, liver, lung or kidney problems, ulceration in the stomach or bowels, poor general condition, received any vaccinations or if are due to have any, diabetes, ascites (fluid in the stomach area), lung problems or fluid in the lungs. Methorapfs 20 Injection 0.4 ml may cause a serious, life-threatening reaction. If you experience symptoms such as rash, itching, hives, throat tightness, trouble swallowing, swelling of the face, throat, lips, or tongue; runny or stuffy nose, lightheadedness or dizziness, chest pain, difficulty breathing, wheezing, or feeling faint, consult your doctor immediately. Inform your doctor if you are undergoing radiation therapy; if you receive Methorapfs 20 Injection 0.4 ml while you are being treated with radiation therapy for cancer, it may cause damage to the skin, bones, or other parts of the body.
Drug-Drug Interactions: Methorapfs 20 Injection 0.4 ml may have interaction with pain killers/NSAIDs, an antineoplastic agent (cisplatin), immunosuppressants (mercaptopurine, azathioprine), antibiotics (tetracycline, chloramphenicol), anti-inflammatory agents (sulfasalazine), retinoids.
Drug-Food Interactions: Avoid consuming alcohol whilst on treatment with Methorapfs 20 Injection 0.4 ml.
Drug-Disease Interactions: Inform your doctor if you have immunodeficiency conditions, bone marrow problems, low white blood cell count, low platelet count, serious anaemia, liver problems due to alcohol abuse, or chronic liver disease.
Arthritis:
Psoriasis:
Cancer:
Rheumatoid arthritis: It is an autoimmune disease (the body's immune system attacks its tissue) that leads to joint pain and damage. Symptoms of rheumatoid arthritis include pain, inflammation of joints, difficulty moving, and swelling.
Psoriasis: It is a chronic autoimmune skin condition that causes the skin to multiply ten times faster than normal. This leads to a rapid build-up of skin cells, causing scaling on the skin surface. Symptoms include inflamed, red, raised patches of skin, soreness around the patches, itching, burning sensations, painful, swollen joints, and dry skin.
Cancer: It is a genetic change in which the cells divide uncontrollably and spread into surrounding tissues. There are two types of cancer, namely benign (localized) and metastatic (spread to the whole body). Cancer growth can be prevented by chemotherapy (by strong antibiotics), radiation, and stem cell therapy.
Alcohol
Unsafe
You are recommended to avoid alcohol consumption while taking Methorapfs 20 Injection 0.4 ml.
Pregnancy
Unsafe
Methorapfs 20 Injection 0.4 ml may cause serious birth defects. It is not recommended to take Methorapfs 20 Injection 0.4 ml while you are pregnant.
Breast Feeding
Unsafe
Methorapfs 20 Injection 0.4 ml passes into breast milk. Avoid breastfeeding whilst on treatment with Methorapfs 20 Injection 0.4 ml and for at least 1 week after the last dose.
Driving
Caution
Methorapfs 20 Injection 0.4 ml may cause dizziness and tiredness; do not drive or operate heavy machinery until you know how Methorapfs 20 Injection 0.4 ml affects you.
Liver
Caution
Please consult your doctor if you have liver impairment before taking Methorapfs 20 Injection 0.4 ml.
Kidney
Caution
Please consult your doctor if you have kidney impairment before taking Methorapfs 20 Injection 0.4 ml.
Children
Caution
The efficacy and safety of Methorapfs 20 Injection 0.4 ml in children have been established in polyarticular-course juvenile rheumatoid arthritis and cancer chemotherapy. Please consult your doctor if you have any concerns regarding the usage of Methorapfs 20 Injection 0.4 ml in children.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Product Substitutes